BIB vs. UVXY
BIB (ProShares Ultra Nasdaq Biotechnology) and UVXY (ProShares Ultra VIX Short-Term Futures ETF) are both exchange-traded funds - BIB is a Leveraged Equities fund tracking the NASDAQ Biotechnology Index (200%), while UVXY is a Volatility fund tracking the S&P 500 VIX SHORT-TERM FUTURES TR (150%). Both are passively managed. Over the past 10 years, BIB returned 9.71%/yr vs -73.85%/yr for UVXY. At a correlation of -0.54, they often move in opposite directions. Both charge a 0.95% expense ratio.
Performance
BIB vs. UVXY - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, BIB achieves a 12.50% return, which is significantly higher than UVXY's -22.07% return. Over the past 10 years, BIB has outperformed UVXY with an annualized return of 9.71%, while UVXY has yielded a comparatively lower -73.85% annualized return.
BIB
- 1D
- 1.97%
- 1M
- 9.49%
- YTD
- 12.50%
- 6M
- 8.62%
- 1Y
- 100.86%
- 3Y*
- 19.65%
- 5Y*
- -0.74%
- 10Y*
- 9.71%
UVXY
- 1D
- 8.28%
- 1M
- -14.92%
- YTD
- -22.07%
- 6M
- -24.28%
- 1Y
- -74.07%
- 3Y*
- -61.96%
- 5Y*
- -66.90%
- 10Y*
- -73.85%
BIB vs. UVXY - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
BIB ProShares Ultra Nasdaq Biotechnology | 12.50% | 59.21% | -9.84% | -1.06% | -28.85% | -6.02% | 39.79% | 46.71% | -24.93% | 40.49% |
UVXY ProShares Ultra VIX Short-Term Futures ETF | -22.07% | -65.32% | -50.90% | -87.70% | -44.81% | -88.33% | -17.38% | -84.23% | 60.10% | -94.17% |
Correlation
The correlation between BIB and UVXY is -0.38, meaning they tend to move in opposite directions. This is especially valuable for risk management - when one declines, the other has historically tended to hold steady or rise.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | -0.38 |
Correlation (3Y) Calculated over the trailing 3-year period | -0.45 |
Correlation (5Y) Calculated over the trailing 5-year period | -0.50 |
Correlation (10Y) Calculated over the trailing 10-year period | -0.52 |
Correlation (All Time) Calculated using the full available price history since Oct 4, 2011 | -0.54 |
The correlation between BIB and UVXY shifts across timeframes, from -0.54 (all time) to -0.38 (1 year), reflecting how their relationship changes across market environments.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
BIB vs. UVXY — Risk / Return Rank
BIB
UVXY
BIB vs. UVXY - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for ProShares Ultra Nasdaq Biotechnology (BIB) and ProShares Ultra VIX Short-Term Futures ETF (UVXY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| BIB | UVXY | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +3.38 | ||
| Sortino ratioReturn per unit of downside risk | +4.72 | ||
| Omega ratioGain probability vs. loss probability | 1.36 | 0.81 | +0.55 |
| Calmar ratioReturn relative to maximum drawdown | 5.99 | -1.01 | +7.00 |
| Martin ratioReturn relative to average drawdown | 18.30 | -1.45 | +19.75 |
Loading charts...
Drawdowns
BIB vs. UVXY - Drawdown Comparison
The maximum BIB drawdown since its inception was -67.24%, smaller than the maximum UVXY drawdown of -100.00%. Use the drawdown chart below to compare losses from any high point for BIB and UVXY.
Loading charts...
Drawdown Indicators
| BIB | UVXY | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -67.24% | -100.00% | +32.76% |
Max Drawdown (1Y)Largest decline over 1 year | -16.92% | -73.51% | +56.59% |
Max Drawdown (3Y)Largest decline over 3 years | -45.30% | -94.93% | +49.63% |
Max Drawdown (5Y)Largest decline over 5 years | -65.86% | -99.71% | +33.85% |
Max Drawdown (10Y)Largest decline over 10 years | -66.20% | -100.00% | +33.80% |
Current DrawdownCurrent decline from peak | -17.29% | -100.00% | +82.71% |
Average DrawdownAverage peak-to-trough decline | -32.71% | -98.75% | +66.04% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 5.53% | 55.34% | -49.81% |
Volatility
BIB vs. UVXY - Volatility Comparison
The current volatility for ProShares Ultra Nasdaq Biotechnology (BIB) is 13.56%, while ProShares Ultra VIX Short-Term Futures ETF (UVXY) has a volatility of 25.85%. This indicates that BIB experiences smaller price fluctuations and is considered to be less risky than UVXY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| BIB | UVXY | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 13.56% | 25.85% | -12.29% |
Volatility (6M)Calculated over the trailing 6-month period | 31.65% | 66.46% | -34.81% |
Volatility (1Y)Calculated over the trailing 1-year period | 40.43% | 85.46% | -45.03% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 43.60% | 103.96% | -60.36% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 46.39% | 112.39% | -66.00% |
BIB vs. UVXY - Expense Ratio Comparison
Both BIB and UVXY have an expense ratio of 0.95%.
Dividends
BIB vs. UVXY - Dividend Comparison
BIB's dividend yield for the trailing twelve months is around 0.55%, while UVXY has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
BIB ProShares Ultra Nasdaq Biotechnology | 0.55% | 0.77% | 1.69% | 0.07% | 0.03% |
UVXY ProShares Ultra VIX Short-Term Futures ETF | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
BIB and UVXY have a correlation of -0.38, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
UVXY has higher volatility (25.85%) compared to BIB (13.56%). In terms of maximum drawdown, BIB dropped -67.24% vs UVXY's -100.00%.
On 10-year performance, BIB leads with 9.71% vs -73.85% for UVXY. Both ETFs have the same 0.95% expense ratio. On volatility, BIB has been the lower-risk option at 13.56%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 10-year period, BIB has performed better with a 9.71% return vs -73.85%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
BIB and UVXY have the same expense ratio: 0.95% per year.
BIB has the higher dividend yield at 0.55%, compared with 0.00% for UVXY.
BIB is categorized as Leveraged Equities, while UVXY is Volatility. BIB tracks NASDAQ Biotechnology Index (200%), while UVXY tracks S&P 500 VIX SHORT-TERM FUTURES TR (150%).
BIB currently has the higher Sharpe Ratio (2.51 vs -0.87), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for BIB and UVXY
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer